The phase II research examines the basic safety and possible great things about CERE-110.
CERE-110 trial to avoid the progression of Alzheimer’s disease Researchers in the Memory Disorders Program in Georgetown University Medical Center are actually recruiting volunteers for a national gene therapy trial – the first study of its kind for the treating patients with dementia because of Alzheimer’s disease. The phase II research examines the basic safety and possible great things about CERE-110. CERE-110 includes a gene and is definitely injected during surgery right into a section of the brain suffering from Alzheimer’s disease levitrasverige.net . The gene will instruct human brain cells to create more of a protein, called Nerve Growth Element or NGF, which assists nerve cells survive and function correctly. The transfer of the gene into the mind is definitely a medical technique known as gene therapy.
CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment CEL-SCI has signed a co-development and profit sharing contract with Ergomed Clinical Analysis for CEL-SCI’s investigational immunotherapy medication Multikine in HIV/HPV co-infected ladies with cervical dysplasia. Ergomed already includes a similar co-development contract made in April for $10 million with CEL-SCI for a continuing head and neck malignancy Phase III scientific trial. Ergomed will receive its return on investment predicated on an agreed single-digit %age of any net gain received by CEL-SCI for Multikine from product sales in this and the head and neck tumor indications.